Record Date

Caplin Point Laboratories has announced a board meeting outcome declaring an interim dividend of ₹3.00 per share (150% on ₹2 face value). The record date for dividend eligibility is May 30, 2025. FY25 total revenue rose 15.5% YoY to ₹2,034 Cr, with PAT up 17.3% to ₹541 Cr.

Strong cash flows and ongoing capacity expansion support growth in emerging and regulated markets.